Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > apis> gpcr-g-protein
Catalog name Description price
R-R-4248 NBI-74330 CAS No.855527-92-3 NBI-74330/CAS No.855527-92-3 is a potent antagonist for CXCR3, and exhibits potent inhibition of (125I)CXCL10 and (125I)CXCL11 specific binding with Ki of 1.5 and 3.2 nM, respectively. price>
R-R-4249 VUF11207 fumarate CAS No.1785665-61-3 VUF11207 fumarate/CAS No.1785665-61-3 is a CXCR7 agonist that binds specifically to CXCR7. VUF11207 fumarate reduces CXCL12-mediated osteoclastogenesis and bone resorption by inhibiting ERK phosphorylation. price>
R-R-4250 IT1t dihydrochloride CAS No.1092776-63-0 IT1t dihydrochloride/CAS No.1092776-63-0 is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. price>
R-R-4251 PS372424 hydrochloride CAS No.1596362-29-6 PS372424 hydrochloride/CAS No.1596362-29-6, a three amino-acid fragment of CXCL10, is a specific human CXCR3 agonist with anti-inflammatory activity. PS372424 hydrochloride prevents human T-cell migration in a humanized model of arthritic inflammation. price>
R-R-4252 Reparixin L-lysine salt CAS No.266359-93-7 Reparixin L-lysine salt/CAS No.266359-93-7 is an allosteric inhibitor of chemokine receptor 1/2 (CXCR1/2) activation. price>
R-R-4253 TC14012 CAS No.368874-34-4 TC14012/CAS No.368874-34-4, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity. price>
R-R-4254 Kynurenic acid-d5 CAS No.350820-13-2 Kynurenic acid-d5/CAS No.350820-13-2 is the deuterium labeled Kynurenic acid. Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid is also an agonist of GPR35/CXCR8. price>
R-R-4255 Kynurenic acid sodium CAS No.2439-02-3 Kynurenic acid sodium/CAS No.2439-02-3, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8. price>
R-R-4256 Nicotinamide N-oxide CAS No.1986-81-8 Nicotinamide N-oxide/CAS No.1986-81-8, an in vivo nicotinamide metabolite, is a potent, and selective antagonist of the CXCR2 receptor. price>
R-R-4257 Burixafor hydrobromide CAS No.1191450-19-7 Burixafor hydrobromide (TG-0054 hydrobromide)/CAS No.1191450-19-7 is an orally bioavailable and potent antagonist of CXCR4 and a well anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobromide) mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction. price>